Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer A Parikh

Showing results (31-40 of 182) with videos related to

Pageof 19
Sort By:
Leukemia & Lymphoma|December 15, 2016
Disseminated herpes zoster in chronic lymphocytic leukemia (CLL) patients treated with B-cell receptor pathway inhibitorsKarthik V Giridhar, Tait Shanafelt, Pritish K Tosh, et al.
Leukemia & Lymphoma|December 30, 2009
Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosisSameer A Parikh, Hagop M Kantarjian, Mary Ann Richie, et al.
Blood Cancer Journal|October 6, 2022
Fatal Powassan virus encephalitis in patients with chronic lymphocytic leukemiaIsla M Johnson, Caleb Scheckel, Sameer A Parikh, et al.
Leukemia & Lymphoma|March 12, 2020
Daratumumab as successful initial therapy for AL amyloidosis with nerve involvementShweta Deshpande, Morie A Gertz, Angela Dispenzieri, et al.
Leukemia & Lymphoma|September 7, 2018
Cryptococcus neoformans infections in patients with lymphoproliferative neoplasmsMaria V Dioverti, Sameer A Parikh, Douglas R Osmon, et al.
The New England Journal of Medicine|February 2, 2022
Calm before the StormManuel B Braga Neto, Andrew D Badley, Sameer A Parikh, et al.
British Journal of Haematology|September 2, 2024
Pericardial events associated with ibrutinib-based therapies for chronic lymphocytic leukaemia in two landmark trialsBita Fakhri, Victoria Wang, Gabriela Perez-Burbano, et al.
Leukemia|March 21, 2026
Defining the acute BTK-loss transcriptional program in CLL using a BTK degraderMingma G Sherpa, Sutapa Sinha, Weiguo Han, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 17, 2010
Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosisSameer A Parikh, Hagop Kantarjian, Aaron Schimmer, et al.
American Journal of Hematology|October 22, 2021
Hiding in (not so) plain sight: Spontaneous tumor Lysis syndrome due to intravascular large B cell lymphomaMatthew Ho, Saurabh Zanwar, Patrick Duggan, et al.
Pageof 19

Showing results (31-40 of 182) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|December 15, 2016
Disseminated herpes zoster in chronic lymphocytic leukemia (CLL) patients treated with B-cell receptor pathway inhibitorsKarthik V Giridhar, Tait Shanafelt, Pritish K Tosh, et al.
Leukemia & Lymphoma|December 30, 2009
Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosisSameer A Parikh, Hagop M Kantarjian, Mary Ann Richie, et al.
Blood Cancer Journal|October 6, 2022
Fatal Powassan virus encephalitis in patients with chronic lymphocytic leukemiaIsla M Johnson, Caleb Scheckel, Sameer A Parikh, et al.
Leukemia & Lymphoma|March 12, 2020
Daratumumab as successful initial therapy for AL amyloidosis with nerve involvementShweta Deshpande, Morie A Gertz, Angela Dispenzieri, et al.
Leukemia & Lymphoma|September 7, 2018
Cryptococcus neoformans infections in patients with lymphoproliferative neoplasmsMaria V Dioverti, Sameer A Parikh, Douglas R Osmon, et al.
The New England Journal of Medicine|February 2, 2022
Calm before the StormManuel B Braga Neto, Andrew D Badley, Sameer A Parikh, et al.
British Journal of Haematology|September 2, 2024
Pericardial events associated with ibrutinib-based therapies for chronic lymphocytic leukaemia in two landmark trialsBita Fakhri, Victoria Wang, Gabriela Perez-Burbano, et al.
Leukemia|March 21, 2026
Defining the acute BTK-loss transcriptional program in CLL using a BTK degraderMingma G Sherpa, Sutapa Sinha, Weiguo Han, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 17, 2010
Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosisSameer A Parikh, Hagop Kantarjian, Aaron Schimmer, et al.
American Journal of Hematology|October 22, 2021
Hiding in (not so) plain sight: Spontaneous tumor Lysis syndrome due to intravascular large B cell lymphomaMatthew Ho, Saurabh Zanwar, Patrick Duggan, et al.
Pageof 19